Letao Li

Letao Li is a Researcher in the Pharmacy department at Erasmus MC, specializing in clinical pharmacology with focus on pharmacokinetics and pharmacodynamics in vulnerable patient populations. Affiliated with Rotterdam-based research teams, Li's work bridges pharmaceutical sciences and critical care medicine.

Research interests center on drug behavior in inflammatory conditions, particularly examining how biomarkers like C-reactive protein alter pharmacokinetics in sepsis, pre-eclampsia, and pediatric oncology. Key themes include protein binding dynamics, glucocorticoid therapy optimization, and precision dosing for antibiotics in critically ill patients.

Recent publications reveal strong emphasis on translating pharmacokinetic findings into clinical practice, with trends showing increasing focus on model-informed precision dosing (MIPD) frameworks. The work consistently addresses therapeutic challenges in high-risk groups including neonates, pregnant women, and sepsis patients.

Key research areas:

• Pharmacokinetic alterations during inflammation
• Dexamethasone/betamethasone optimization in special populations
• Temocillin protein binding in critical illness
• Biomarker-guided dosing strategies

Li's collaborative network spans multiple European institutions with significant work in pediatric oncology pharmacology and critical care pharmacotherapy. Current research appears focused on implementing precision dosing algorithms for vulnerable populations through model-informed approaches.